Siegfried Investor Relations Material

Siegfried Holding AG engages in the life sciences business worldwide. The company offers medical devices, instruments, and tools. It also explores and produces magnetic resonance image (MRI) contrast media, as well as medical diagnostic contrast agents in different strengths for use in X-ray imaging; radiolabeled antibodies for radioimmunodetection of malignant tumors; and radioiodinated contrast agents with potential for future use as radiotracers for PET imaging. In addition, it manufactures drug delivery systems such as transdermal systems and transmucosal patches. Siegfried Holding AG sells its products in Europe under several product brands.